Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and ...

The "Sickle Cell Disease Drugs Market - A Global and Regional Analysis: Focus on Route of Administration, Distribution Channel, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report ...

Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, ...

Novartis on Tuesday issued a more optimistic full-year earnings guidance, citing strong growth of drugs such as Kisqali, ...

"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...

Around 1,000 of these jobs will be within the company with the others in supporting roles, including construction. The ...

Tesla’s first-quarter profits plunged by more than two-thirds amid a backlash against Elon Musk’s electric car company that ...

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss ...

The announcement comes as drugmakers unveil investments to deal with tariffs from the Trump administration, which is seeking to boost domestic manufacturing ...

Of course, this isn’t a risk-free enterprise. OXB’s highly dependent on a few key customers (Novartis, AstraZeneca, and Boehringer Ingelheim), which could compromise cash flows if one of these ...